Access Cortisol— 510(k) K223038

Substantially Equivalent

Beckman Coulter, Inc.

FDA 510(k) clearance K223038 for Access Cortisol, Substantially Equivalent on 2023-02-08. Applicant: Beckman Coulter, Inc..

Clearance details

Applicant: Beckman Coulter, Inc.
Product code: Code CGR
Advisory panel: Clinical Chemistry
Date received: 2022-09-29
Decision date: 2023-02-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chaska, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.